Investor List:

Top Therapeutics Series A Investors in Los Angeles / Southern California (21)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Manufacturing (Series B), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Aiden Aceves, Vice President at Insight Partners
Aiden Aceves
Insight Partners·Vice President
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in San Diego (CA)
Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Los Angeles / Southern California (Other Lists), Investors in AI (Series A), Investors in BioTech (Series A), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B)
Photo of Jason Camm, Managing Director at Thiel Capital
Jason Camm
Thiel Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in West Hollywood (CA)
Photo of Teymour Boutros-Gali, Managing Partner at Bold Capital Partners
Teymour Boutros-Gali
Bold Capital Partners·Managing Partner
Sweet spot: $4.0M
Range: $500K - $10.0M
Investors in Santa Monica (CA)
Investors in AR/VR (Series A), Investors in AR/VR (Seed), Investors in Consumer Health (Series A), Investors in IoT (Seed), Investors in Web3/Blockchain (Seed), Investors in Web3/Blockchain (Series A), Investors in BioTech (Seed), Investors in IoT (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in AI (Seed), Investors in Diverse Investors (Other Lists), Investors in AI (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in AR/VR (Seed), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Web3/Blockchain (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Health (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in IoT (Seed), Investors in AI (Series A), Investors in AR/VR (Series A), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Series A), Investors in IoT (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Wellness & Fitness (Series A), Investors in DeepTech (Series A), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Fabian Hansen, Managing Director at Presight Capital
Fabian Hansen
Presight Capital·Managing Director
Sweet spot: $10.0M
Range: $500K - $20.0M
Investors in Los Angeles (CA)
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Health (Seed), Investors in FinTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in FinTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Health IT (Series B), Investors in FinTech (Seed), Investors in Health & Hospital Services (Seed)
Photo of Mark Hahs, Managing Partner at VentureDNA
Mark Hahs
VentureDNA·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Bakersfield (CA)
Investors in Payments (Seed), Investors in IoT (Seed), Investors in Payments (Series A), Investors in BioTech (Seed), Investors in IoT (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Health IT (Seed), Investors in IoT (Seed), Investors in Health & Hospital Services (Series A), Investors in Payments (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Payments (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Justin Dyer, Partner at AWM Capital
Justin Dyer
AWM Capital·Partner
Sweet spot: $500K
Range: $100K - $2.0M
Investors in Los Angeles (CA)
Investors in Parenting/Families (Seed), Investors in Insurance (Seed), Investors in Parenting/Families (Series A), Investors in Parenting/Families (Series B), Investors in Insurance (Series B), Investors in Logistics (Series B), Investors in Insurance (Series A), Investors in Logistics (Seed), Investors in FinTech (Series B), Investors in Logistics (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in FinTech (Seed), Investors in Insurance (Seed), Investors in Parenting/Families (Seed), Investors in Logistics (Seed), Investors in FinTech (Series A), Investors in Insurance (Series A), Investors in Parenting/Families (Series A), Investors in Logistics (Series A), Investors in FinTech (Series B), Investors in Insurance (Series B), Investors in Parenting/Families (Series B), Investors in Logistics (Series B), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series B), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Blake Masters, Principal at Thiel Capital
Blake Masters
Thiel Capital·Principal
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in San Francisco (CA), Investors in Tucson (AZ), Investors in Los Angeles (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Health & Hospital Services (Seed)